“…In this issue, two papers report data on the impact of COVID-19 infection in psychoses treatment and obsessive-compulsive symptoms. Following the abovementioned immunological component of psychiatric disorder and their treatment, the paper in this issue reports on the immunological aspects of COVID-19 infection on neutrophil count in patients using clozapine versus other antipsychotics (Jeong et al, 2024). Results suggest a possible detrimental synergic effect on reducing neutrophil count by both COVID-19 infection and clozapine, which is less evident when other antipsychotics are used.…”